Previous 10 | Next 10 |
The following slide deck was published by TRACON Pharmaceuticals, Inc. in conjunction with this event. For further details see: TRACON Pharmaceuticals (TCON) Investor Presentation - Slideshow
I-MAB BioPharma is a new player in the global pharmaceuticals market with autoimmune products. It has a robust portfolio of marketable drugs with several more in the pipeline. The company has global partnerships and an international footprint that will expand drastically as its ne...
SAN DIEGO, March 09, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform...
SAN DIEGO, March 08, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing a product development platform to partner with ex-U.S. comp...
SAN DIEGO, March 02, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform...
Tracon Pharmaceuticals shares are up ~400% since the beginning of September 2020, owing to excitement surrounding its lead asset, subcutaneously administrated envafolimab. This recent runup still places the stock down ~90% from its 2014 IPO price. With somewhat de-risked data from...
TRACON Pharmaceuticals, Inc. (TCON) Q4 2020 Earnings Conference Call February 25, 2021 4:30 PM ET Company Participants Charles Theuer - CEO Scott Brown - CFO Conference Call Participants Maury Raycroft - Jefferies Jason McCarthy - Maxim Group Bert Hazlett - BTIG Presentation Operator Good day...
Tracon (TCON): Q4 GAAP EPS of -$0.31 beats by $0.10.Cash, cash equivalents and short-term investments were $36.1M at year end. Press Release For further details see: Tracon EPS beats by $0.10
SAN DIEGO, Feb. 25, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform t...
SAN DIEGO, Feb. 18, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO-independent product development platform t...
News, Short Squeeze, Breakout and More Instantly...
TRACON Pharmaceuticals Inc. Company Name:
TCON Stock Symbol:
OTCMKTS Market:
TRACON Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Yoshitsu Co. Ltd (TKLF) rose 103.4% to $0.623 on volume of 309,019,720 shares Maxeon Solar Technologies Ltd. (MAXN) rose 11.2% to $0.2524 on volume of 226,231,487 shares NVIDIA Corporation (NVDA) fell 1.6% to $126.36 on volume of 208,...
A look at the top 10 most actives in the United States American Rebel Holdings Inc. (AREB) rose 60.3% to $0.83355 on volume of 56,112,820 shares DatChat Inc. (DATS) rose 71.2% to $1.78 on volume of 33,845,116 shares Autonomix Medical Inc. (AMIX) rose 97.4% to $1.22 on volume of 33,054,234...
A look at the top 10 most actives in the United States Maxeon Solar Technologies Ltd. (MAXN) rose 35.3% to $0.3248 on volume of 164,333,109 shares SRIVARU Holding Limited (SVMH) rose 62.4% to $0.2581 on volume of 68,213,933 shares NVIDIA Corporation (NVDA) rose 2.9% to $129.43 on volume o...